ATE468138T1 - Neue kombinationen eines 5-ht3 rezeptorantagonisten mit racecadotril oder dexecadotril - Google Patents

Neue kombinationen eines 5-ht3 rezeptorantagonisten mit racecadotril oder dexecadotril

Info

Publication number: ATE468138T1
Authority: AT; Austria
Prior art keywords: dexecadotril; racecadotril; receptor antagonist; new combinations; combinations
Prior art date: 2004-02-12

Application number

AT05702484T

Other languages

English (en)

Inventor

Jean-Charles Schwartz

Jeanne-Marie Lecomte

Original Assignee

Bioprojet Soc Civ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-12

Filing date

2005-02-14

Publication date

2010-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE468138(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-02-14 Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ

2010-06-15 Application granted granted Critical

2010-06-15 Publication of ATE468138T1 publication Critical patent/ATE468138T1/de

Links

ODUOJXZPIYUATO-UHFFFAOYSA-N 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester Chemical compound C=1C=CC=CC=1COC(=O)CNC(=O)C(CSC(=O)C)CC1=CC=CC=C1 ODUOJXZPIYUATO-UHFFFAOYSA-N 0.000 title 1
229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 title 1
ODUOJXZPIYUATO-IBGZPJMESA-N benzyl 2-[[(2r)-2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate Chemical compound C([C@@H](CSC(=O)C)C(=O)NCC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 ODUOJXZPIYUATO-IBGZPJMESA-N 0.000 title 1
108700010883 dexecadotril Proteins 0.000 title 1
229950008996 dexecadotril Drugs 0.000 title 1
108700040249 racecadotril Proteins 0.000 title 1
229960002281 racecadotril Drugs 0.000 title 1
239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 title 1
206010012735 Diarrhoea Diseases 0.000 abstract 1
229940122586 Enkephalinase inhibitor Drugs 0.000 abstract 1
208000005577 Gastroenteritis Diseases 0.000 abstract 1
239000002111 antiemetic agent Substances 0.000 abstract 1
229940125683 antiemetic agent Drugs 0.000 abstract 1
239000002792 enkephalinase inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Otolaryngology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT05702484T 2004-02-12 2005-02-14 Neue kombinationen eines 5-ht3 rezeptorantagonisten mit racecadotril oder dexecadotril ATE468138T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04290384A EP1563848A1 (de)	2004-02-12	2004-02-12	Neue Kombinationen von Antiemetika und Enkephalinase-Inhibitoren
PCT/IB2005/000351 WO2005079850A1 (en)	2004-02-12	2005-02-14	New combinations of an anti emetic agent and an enkephalinase inhibitor

Publications (1)

Publication Number	Publication Date
ATE468138T1 true ATE468138T1 (de)	2010-06-15

Family

ID=34684783

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05702484T ATE468138T1 (de)	2004-02-12	2005-02-14	Neue kombinationen eines 5-ht3 rezeptorantagonisten mit racecadotril oder dexecadotril

Country Status (28)

Country	Link
US (1)	US8222294B2 (de)
EP (2)	EP1563848A1 (de)
JP (1)	JP4987487B2 (de)
KR (1)	KR101152308B1 (de)
CN (1)	CN1917903B (de)
AT (1)	ATE468138T1 (de)
AU (1)	AU2005215262B2 (de)
BR (1)	BRPI0506631B8 (de)
CA (1)	CA2553827C (de)
CY (1)	CY1110202T1 (de)
DE (1)	DE602005021317D1 (de)
DK (1)	DK1718337T3 (de)
EA (1)	EA010625B1 (de)
EC (1)	ECSP066758A (de)
ES (1)	ES2344909T3 (de)
HR (1)	HRP20100363T1 (de)
MA (1)	MA28354A1 (de)
ME (1)	ME01175B (de)
NO (1)	NO337320B1 (de)
NZ (1)	NZ548635A (de)
PL (1)	PL1718337T3 (de)
PT (1)	PT1718337E (de)
RS (1)	RS51329B (de)
SI (1)	SI1718337T1 (de)
TN (1)	TNSN06246A1 (de)
UA (1)	UA88156C2 (de)
WO (1)	WO2005079850A1 (de)
ZA (1)	ZA200605872B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2900823B1 (fr) *	2006-05-15	2009-02-13	Bioprojet Soc Civ Ile	Nouvelle forme d'administration du racecadotril.
EP2462922A1 (de) *	2010-12-10	2012-06-13	Bioprojet	Neue Darreichungsform für Enkephalinasehemmer
EP2866789B1 (de)	2012-06-28	2018-08-01	Johnson & Johnson Consumer Inc.	Racecadotril-lipidzusammensetzungen
US9114171B2 (en) *	2012-06-28	2015-08-25	Mcneil-Ppc, Inc.	Racecadotril liquid compositions
US9801819B2 (en) *	2012-06-28	2017-10-31	Johnson & Johnson Consumer Inc.	Racecadotril compositions
PT2866802T (pt) *	2012-06-28	2016-09-05	Johnson & Johnson Consumer Inc	Composições líquidas racecadotril
MA40859A (fr)	2014-10-29	2017-09-05	Johnson & Johnson Consumer Inc	Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0028575D0 (en) *	2000-11-23	2001-01-10	Elan Corp Plc	Oral pharmaceutical compositions containing cyclodextrins

2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/de not_active Withdrawn
2005
- 2005-02-14 EP EP05702484A patent/EP1718337B1/de not_active Expired - Lifetime
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/me unknown
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko not_active Expired - Fee Related
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/en not_active Ceased
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es not_active Expired - Lifetime
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 US US10/587,899 patent/US8222294B2/en not_active Expired - Fee Related
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de not_active Expired - Lifetime
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/sr unknown
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
- 2005-02-14 CA CA2553827A patent/CA2553827C/en not_active Expired - Fee Related
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
2010
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown

Also Published As

Publication number	Publication date
CY1110202T1 (el)	2015-01-14
DK1718337T3 (da)	2010-07-26
JP4987487B2 (ja)	2012-07-25
CA2553827C (en)	2012-08-07
SI1718337T1 (sl)	2010-08-31
AU2005215262B2 (en)	2011-03-03
MA28354A1 (fr)	2006-12-01
US8222294B2 (en)	2012-07-17
ECSP066758A (es)	2006-11-24
KR20060132691A (ko)	2006-12-21
BRPI0506631B8 (pt)	2021-05-25
KR101152308B1 (ko)	2012-06-11
CA2553827A1 (en)	2005-09-01
NO20063973L (no)	2006-09-05
EP1718337B1 (de)	2010-05-19
US20070275993A1 (en)	2007-11-29
AU2005215262A1 (en)	2005-09-01
ZA200605872B (en)	2008-01-08
BRPI0506631A (pt)	2007-05-08
EP1718337A1 (de)	2006-11-08
JP2007522202A (ja)	2007-08-09
NO337320B1 (no)	2016-03-07
EA010625B1 (ru)	2008-10-30
PT1718337E (pt)	2010-06-16
DE602005021317D1 (de)	2010-07-01
NZ548635A (en)	2009-10-30
CN1917903A (zh)	2007-02-21
CN1917903B (zh)	2010-07-21
WO2005079850A1 (en)	2005-09-01
ES2344909T3 (es)	2010-09-09
BRPI0506631B1 (pt)	2018-12-04
ME01175B (me)	2013-03-20
EP1563848A1 (de)	2005-08-17
EA200601466A1 (ru)	2006-12-29
RS51329B (sr)	2011-02-28
UA88156C2 (ru)	2009-09-25
TNSN06246A1 (fr)	2007-12-03
PL1718337T3 (pl)	2010-09-30
HRP20100363T1 (hr)	2010-07-31

Legal Events

Date

Code

Title

Description

2010-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1718337

Country of ref document: EP

Publication	Publication Date	Title
EP4167993A4 (de)	2024-07-24	5-oxopyrrolidin-3-carboxamide als nav1.8-inhibitoren
EP3890789A4 (de)	2022-12-14	Radioimmunkonjugat- und checkpoint-inhibitor-kombinationstherapie
ATE479687T1 (de)	2010-09-15	Kinaseinhibitoren
DK1836201T4 (da)	2013-11-11	Pyrrolidininhibitorer af IAP.
EP1942921A4 (de)	2011-03-09	Kombination aus einem dipeptidyl-peptidase-4-hemmer und einem antihypertensiven mittel zur behandlung von diabetes und hypertonie
TW200739269A (en)	2007-10-16	Coating compositions for photoresists
JOP20210050B1 (ar)	2024-12-22	معدلات تعبير pnpla3
TW200834248A (en)	2008-08-16	Liquid-immersion exposure method and liquid-immersion exposure apparatus
DE602004020442D1 (de)	2009-05-20	Roboter-Führungsvorrichtung zur präzisen Bewegung eines Gegenstandes
UY29774A1 (es)	2007-03-30	Inhibidor de atm
CY1110202T1 (el)	2015-01-14	Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης
CY1113071T1 (el)	2016-04-13	Καππα επιλεκτικος ανταγωνιστης οπιοειδους υποδοχεα
BRPI0716791A2 (pt)	2013-09-17	dispositivo e mÉtodo de revestimento para revestir uma superfÍcie de um corpo de luva e luva resultante.
UY30142A1 (es)	2007-09-28	Composiciones antimicoticas ramnolipidas y metodos de uso relacionados
ATE433469T1 (de)	2009-06-15	Polyethylenformungszusammensetzung zur beschichtung von stahlrohren
ATE372357T1 (de)	2007-09-15	Multimodale polyethylenzusammensetzung für rohre
EA200970407A1 (ru)	2009-12-30	Ингибиторы киназ mapk/erk
EP2545412A4 (de)	2013-11-13	Gegenüber aktinischer strahlung empfindliche bzw. strahlungsempfindliche harzzusammensetzung, resistfilm damit und strukturbildungsverfahren damit
IL284857A (en)	2021-08-31	Methods of treating tyrosine kinase inhibitor-induced diarrhea
EP3884959A4 (de)	2022-08-10	Inhibitor der zellulären eisenaufnahme
DE602004019697D1 (de)	2009-04-09	Ep2-rezeptoragonisten
EP1891924A4 (de)	2013-07-17	Zusammensetzung zum schutz der körperoberfläche
TW200617028A (en)	2006-06-01	Top anti-reflective coating composition and method for pattern formation of semiconductor device using the same
DE10256506B4 (de)	2005-03-10	Optimierung der Ausleuchtung eines Projektionsapparates
NO20076566L (no)	2008-02-22	Ny fremgangsmate for behandling av hyperlipidemi